Legend Biotech (LEGN) News Today $22.66 +1.10 (+5.11%) As of 12:31 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Legend Biotech Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Legend Biotech (LEGN) Stock Could Trade Below Its Sales BackdropOctober 28 at 7:20 AM | finance.yahoo.comLegend Biotech to Host Investor Conference Call on Third Quarter 2026 ResultsOctober 27 at 8:00 AM | globenewswire.comLegend Biotech (NASDAQ:LEGN) Stock Price Crosses Above 50 Day Moving Average - Should You Sell?October 27 at 4:39 AM | marketbeat.comLegend Biotech (NASDAQ:LEGN) Stock Jumps 4.9% - Here's What HappenedOctober 26 at 11:59 AM | marketbeat.comLegend Biotech: Carvykti Makes Billions, But The Profits Are ElusiveOctober 22, 2026 | seekingalpha.comLegend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Stock Rated "Moderate Buy" by Wall Street AnalystsOctober 21, 2026 | marketbeat.comHC Wainwright Forecasts Stronger Earnings for Legend BiotechOctober 18, 2026 | americanbankingnews.comLegend Biotech Wins FDA IND Clearance for First Dual-Target In Vivo CAR-T LB2501October 17, 2026 | theglobeandmail.comQ4 EPS Estimates for Legend Biotech Raised by HC WainwrightOctober 17, 2026 | americanbankingnews.comHC Wainwright Raises Earnings Estimates for Legend BiotechOctober 16, 2026 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and UnitedHealth (UNH)October 15, 2026 | theglobeandmail.comLegend Biotech Receives FDA Clearance for In Vivo CAR-T Therapy TrialOctober 15, 2026 | finance.yahoo.comLegend Biotech Wins FDA Clearance For In Vivo CAR-T Therapy LB2501; Stock UpOctober 15, 2026 | rttnews.comLegend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T TherapyOctober 15, 2026 | globenewswire.comHC Wainwright Boosts Earnings Estimates for Legend BiotechOctober 15, 2026 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Stock Price Up 4.5% - Should You Buy?October 14, 2026 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Stock Price Target Lowered at BarclaysOctober 13, 2026 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Given New $33.00 Price Target at JPMorgan Chase & Co.October 9, 2026 | marketbeat.comRoyal Bank Of Canada Has Lowered Expectations for Legend Biotech (NASDAQ:LEGN) Stock PriceOctober 8, 2026 | marketbeat.comLegend Biotech (LEGN) Tests Its Valuation After Fresh CARVYKTI Five Year DataOctober 4, 2026 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Legend Biotech (LEGN)October 3, 2026 | theglobeandmail.comLegend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS SaysOctober 2, 2026 | finance.yahoo.comInsider Selling: Legend Biotech (NASDAQ:LEGN) Director Sells $258,920.20 in StockOctober 2, 2026 | insidertrades.comLegend Biotech (NASDAQ:LEGN) Director Corazon (Corsee) Sanders Sells 27,370 Shares of StockOctober 1, 2026 | marketbeat.comLegend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple MyelomaOctober 1, 2026 | globenewswire.comLegend Biotech (NASDAQ:LEGN) Shares Up 5.8% - Still a Buy?September 30, 2026 | marketbeat.comLegend Biotech Corporation Presents Five-Year Follow-Up Data from Cartitude-2 Cohort A Evaluating Carvykti in Patients with Relapsed/Refractory Multiple MyelomaSeptember 25, 2026 | marketscreener.comMLegend Biotech Says Five-Year Carvykti Data Show 50% of Patients Remained Progression-Free and AliveSeptember 25, 2026 | finance.yahoo.comCan Legend Biotech (LEGN) Turn Cell Therapy Scale Into Compounding Wealth?September 25, 2026 | finance.yahoo.comLegend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single InfusionSeptember 25, 2026 | globenewswire.comInsider Selling: Legend Biotech (NASDAQ:LEGN) CFO Sells 5,430 SharesSeptember 24, 2026 | insidertrades.comLEGN’s new CEO from Novartis paves way for buyout speculationSeptember 15, 2026 | msn.comLegend Biotech Appoints Ingrid Zhang as CEOSeptember 15, 2026 | finance.yahoo.comLegend Biotech taps Novartis veteran Zhang as CEOSeptember 15, 2026 | reuters.comLegend Biotech Appoints Ingrid Zhang as Chief Executive OfficerSeptember 15, 2026 | globenewswire.comLegend Biotech is tapping a Novartis executive to run the cell-therapy maker, ending a nearly two-month search that began when former CEO Ying Huang resigned in JulySeptember 15, 2026 | wsj.comBarclays Sticks to Its Buy Rating for Legend Biotech (LEGN)September 12, 2026 | theglobeandmail.comRBC Capital Sticks to Its Buy Rating for Legend Biotech (LEGN)September 12, 2026 | theglobeandmail.comLegend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual MeetingSeptember 10, 2026 | globenewswire.comLegend Biotech (LEGN) Heads To Morgan Stanley Conference, Is The 57% Valuation Gap Justified?September 2, 2026 | finance.yahoo.comLegend Biotech to Participate in the Morgan Stanley Global Healthcare ConferenceSeptember 1, 2026 | globenewswire.comLegend Biotech Corporation (LEGN)August 23, 2026 | finance.yahoo.comAnalysts Conflicted on These Healthcare Names: Legend Biotech (LEGN), GoodRx Holdings (GDRX) and CytomX Therapeutics (CTMX)August 15, 2026 | theglobeandmail.comLegend Biotech (LEGN) Receives a Buy from Morgan StanleyAugust 13, 2026 | theglobeandmail.comLegend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer SaysAugust 13, 2026 | finance.yahoo.comLegend Biotech downgraded at Oppenheimer on CEO exit, competitionAugust 12, 2026 | seekingalpha.comLegend's Pipeline Is Starting To MatterAugust 12, 2026 | seekingalpha.comLegend Biotech (LEGN) Earnings: What to Watch When Carvykti ReportsAugust 11, 2026 | 247wallst.comLegend Biotech Reports Second Quarter 2026 Results and Recent HighlightsAugust 11, 2026 | markets.businessinsider.comLegend Biotech shares rise 5% as Q2 earnings and revenue beat estimatesAugust 11, 2026 | msn.com Legend Biotech Media Mentions By Week Legend Biotech Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼0.880.69▲Average Healthcare News Sentiment Legend Biotech News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼65▲LEGN Articles Average Week Legend Biotech Trends on MarketBeatThis week vs. last weekNew Followers1-50%Searches1Page Views3,173-17% Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ASND News HALO News BBIO News SMMT News BMRN News MDGL News IBRX News PCVX News KRYS News KYMR News News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Legend Biotech dated 10/28/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredThe chip inside every TeslaEvery Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...Behind the Markets | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Corporation Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
